Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
- 1 May 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 61 (5), 920-924
- https://doi.org/10.1161/01.cir.61.5.920
Abstract
To evaluate the role of the renin-angiotensin system and sodium depletion in the hypotensive response to 1-sarcosine-8-alanine-angiotensin II (saralasin), 15 male patients with essential hypertension were studied on a diet containing 120 mEq of sodium and 100 mEq of potassium per day. After a 5-day control period, all subjects had a mild pressor response to the saralasin infusion (p less than 0.01). After 5 days of the diuretic metolazone (5 mg/day), eight of the 15 patients had a vasodepressor response; these responders had a significantly greater increase in plasma renin activity and angiotensin II concentrations than did the non-responders. Sodium deficit differed markedly (p less than 0.001) between the two groups (361 +/- 121 mEq (SD) vs 52 +/- 26 mEq sodium, respectively). The addition of spironolactone (400 mg/day) for 5 days resulted in saralasin responsiveness in all but two patients, both of whom had small sodium deficits. Thus, variability in the natriuretic response to diuretics may affect saralasin testing and limit its clinical utility.This publication has 23 references indexed in Scilit:
- The saralasin test for renovascular hypertension/current statusThe American Journal of Cardiology, 1979
- Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients.Circulation, 1978
- Renin, Sodium, and Vasodepressor Response to Saralasin in Renovascular and Essential HypertensionAnnals of Internal Medicine, 1977
- Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patientsEuropean Journal of Clinical Pharmacology, 1977
- Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasinThe American Journal of Medicine, 1976
- Influence of angiotensinase inhibitors on the enzymatic activity of reninBiochemical Medicine, 1976
- Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosisKidney International, 1976
- Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patientsThe American Journal of Medicine, 1976
- Angiotensin blockade: Its clinical significanceThe American Journal of Medicine, 1976
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973